1. Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?. Issue 5 (13th January 2020) Authors: Andrews, Jack R.; Ahmed, Mohamed E.; Karnes, R. Jeffrey; Kwon, Eugene; Bryce, Alan H. Journal: Prostate Issue: Volume 80:Issue 5(2020) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prognostic role of 11C‐choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. Issue 1 (11th October 2021) Authors: Jimbo, Masaya; Andrews, Jack R.; Ahmed, Mohamed E.; Dundar, Ayca; Karnes, R. Jeffrey; Bryce, Alan H.; Kendi, Ayse T.; Kwon, Eugene D.; Lowe, Val J.; Bold, Michael S. Journal: Prostate Issue: Volume 82:Issue 1(2022) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Issue 7 (1st April 2021) Authors: Ledet, Elisa M.; Burgess, Earle F.; Sokolova, Alexandra O.; Jaeger, Ellen B.; Hatton, Whitley; Moses, Marcus; Miller, Patrick; Cotogno, Patrick; Layton, Jodi; Barata, Pedro; Lewis, Brian E.; Nakazawa, Mari; Zhu, Jason; Dellinger, Beth; Elrefai, Sara; Nafissi, Nellie N.; Egan, Jan B.; Shore, Neal;... Journal: Prostate Issue: Volume 81:Issue 7(2021) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Genomic profiling proves metastasis of cutaneous melanoma to vitreal fluid. Issue 6 (December 2020) Authors: Padrnos, Leslie J.; Houghton, Odette M.; Iacob, Codrin E.; Kurli, Madhavi; Ocal, Idris T.; Bryce, Alan H. Journal: Melanoma research Issue: Volume 30:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site. (November 2020) Authors: Zarei, Shabnam; Voss, Jesse S.; Jin, Long; Jenkins, Sarah M.; Bryce, Alan H.; Erickson, Lori A.; Bell, Debra A.; Kipp, Benjamin R.; Flotte, Thomas J. Journal: International journal of gynecological pathology Issue: Volume 39:Number 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies. Issue 9 (September 2021) Authors: Xie, Zhuoer; Saliba, Antoine N.; Abeykoon, Jithma; Majeed, Umair; Almquist, Daniel R.; Wiedmeier-Nutor, Julia E.; Bezerra, Evandro; Andrade-Gonzalez, Xavier; Hickman, Ashley; Sorenson, Karl; Rakshit, Sagar; Wee, Christopher; Tella, Sri Harsha; Kommalapati, Anuhya; Abdallah, Nadine; Pritchett, Jos... Journal: JCO oncology practice Issue: Volume 17:Issue 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours. (July 2022) Authors: Karp, Daniel D.; Camidge, D. Ross; Infante, Jeffery R.; Ames, Tyler D.; Price, Matthew R.; Jimeno, José; Bryce, Alan H. Journal: EClinicalMedicine Issue: Volume 49(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer. (28th September 2022) Authors: Aggarwal, Rahul; Alumkal, Joshi J.; Szmulewitz, Russell Z.; Higano, Celestia S.; Bryce, Alan H.; Lopez-Gitlitz, Angela; McCarthy, Sharon A.; Miladinovic, Branko; McQuarrie, Kelly; Thomas, Shibu; Zhang, Ke; Small, Eric J. Other Names: Goyal Shikha Academic Editor. Journal: Prostate cancer Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer. Issue 6 (12th April 2022) Authors: Qin, Sisi; Gao, Huanyao; Kim, Wootae; Zhang, Huan; Gu, Yayun; Kalari, Krishna R.; Sinnwell, Jason P.; Scholz, Jodi A.; Xie, Fang; Yin, Ping; Yu, Jia; Qin, Bo; Zhuang, Yongxian; Wei, Lixuan; Tan, Winston; Bryce, Alan H.; Weinshilboum, Richard M.; Wang, Liewei Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 6(2022) Page Start: 1296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer. (3rd December 2020) Authors: Sena, Laura A.; Fountain, Julia; Isaacsson Velho, Pedro; Lim, Su Jin; Wang, Hao; Nizialek, Emily; Rathi, Nityam; Nussenzveig, Roberto; Maughan, Benjamin L.; Velez, Miguel Gonzalez; Ashkar, Ryan; Larson, Amanda C.; Pritchard, Colin C.; Adra, Nabil; Bryce, Alan H.; Agarwal, Neeraj; Pardoll, Drew M.... Journal: Oncologist Issue: Volume 26:Number 2(2021) Page Start: e270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗